Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China

Clinical Rheumatology

Volumn 37, Issue 1, 2018, Pages 93-100

  Liu, Ai Chun ^a   Yang, Yue ^a   Li, Meng Tao ^b   Jia, Yuan ^a   Chen, Sheng ^c   Ye, Shuang ^c   Zeng, Xiang Zong ^d   Wang, Zhao ^d   Zhao, Jin Xia ^e   Liu, Xiang Yuan ^e   Zhu, Jian ^f   Zhao, Yan ^b   Zeng, Xiao Feng ^b   Li, Zhan Guo ^a  

^a Tsinghua University   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e PEKING UNIVERSITY THIRD HOSPITAL   (China)

^f CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Ferritins; Lupus erythematosus, systemic; Macrophage activation syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; CASE CONTROL STUDY; CHINA; CLINICAL TRIAL; COMPLICATION; FEMALE; HUMAN; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; MULTICENTER STUDY; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHINA; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85017429467     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-017-3625-6     Document Type: Article

References (42)

1. Gupta S, Weitzman S (2010) Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 61:137–154 DOI: 10.1586/eci.09.58
2. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, Atsumi T, Koike T (2008) Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 47(11):1686–1691. doi:10.1093/rheumatology/ken342 DOI: 10.1093/rheumatology/ken342
3. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint BG, Kumar V (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286(5446):1957–1959 DOI: 10.1126/science.286.5446.1957
4. Kim JM, Kwok SK, Ju JH, Kim HY, Park SH (2012) Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case-control study and literature review. J Rheumatol 39(1):86–93. doi:10.3899/jrheum.110639 DOI: 10.3899/jrheum.110639
5. Rosado FG, Kim AS (2013) Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol 139(6):713–727. doi:10.1309/AJCP4ZDKJ4ICOUAT DOI: 10.1309/AJCP4ZDKJ4ICOUAT
6. Liu Y, Zhou S, Zhang L, Xu L, Jin Y, Liu A, Zhang X, Yao H, Jia Y, Zhang X, Su Y, Li Z (2015) Analyses of 77 patients with hemophagocytic syndrome. Zhonghua Yi Xue Za Zhi 95(9):681–684
7. Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, Li P, Yang G, Wang M, Zhang R, Yang Y (2015) Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis 15:10–20. doi:10.1186/s13023-015-0224-y
8. Li J, Wang Q, Zheng W, Ma J, Zhang W, Wang W, Tian X (2014) Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93(2):100–105. doi:10.1097/MD.0000000000000022 DOI: 10.1097/MD.0000000000000022
9. Kumakura S, Murakawa Y (2014) Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol 66(8):2297–2307. doi:10.1002/art.38672 DOI: 10.1002/art.38672
10. Janka GE, Lehmberg K (2014) Hemophagocytic syndromes—an update. Blood Rev 28(4):135–142. doi:10.1016/j.blre.2014.03.002 DOI: 10.1016/j.blre.2014.03.002
11. Vilaiyuk S, Sirachainan N, Wanitkun S, Pirojsakul K, Vaewpanich J (2013) Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 3(6):899–904. doi:10.1007/s10067-013-2227-1 DOI: 10.1007/s10067-013-2227-1
12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725 DOI: 10.1002/art.1780400928
13. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131 DOI: 10.1002/pbc.21039
14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640
15. Parodi A, Davì S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, Miettunen P, Bader-Meunier B, Espada G, Sterba G, Ozen S, Wright D, Magalhães CS, Khubchandani R, Michels H, Woo P, Iglesias A, Guseinova D, Bracaglia C, Hayward K, Wouters C, Grom A, Vivarelli M, Fischer A, Breda L, Martini A, Ravelli A, Lupus Working Group of the Paediatric Rheumatology European Society (2009) Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 60(11):3388–3399. doi:10.1002/art.24883 DOI: 10.1002/art.24883
16. Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J, Kirwan J, Köhler L, Van Riel P, Vischer T, Bijlsma JW (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718–722 DOI: 10.1136/ard.61.8.718
17. Kumakura S, Ishikura H, Umegae N, Yamagata S, Kobayashi S (1997) Autoimmune-associated hemophagocytic syndrome. Am J Med 102(1):113–115 DOI: 10.1016/S0002-9343(97)89509-5
18. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S (2004) Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 14(3):205–215 DOI: 10.3109/s10165-004-0293-6
19. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B (2003) Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 49(5):633–639 DOI: 10.1002/art.11368
20. Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, Amoura Z, Godeau B, Piette JC, Delfraissy JF (2006) Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore) 85(3):169–182 DOI: 10.1097/01.md.0000224708.62510.d1
21. Tumian NR, Wong CL (2015) Pregnancy-related hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection: a diagnostic and therapeutic challenge. Taiwan J Obstet Gynecol 54(4):432–437. doi:10.1016/j.tjog.2014.11.023 DOI: 10.1016/j.tjog.2014.11.023
22. Qian J, Yang CD (2007) Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol 26(5):807–810 DOI: 10.1007/s10067-006-0245-y
23. Yoshida S, Takeuchi T, Itami Y, Hata K, Watanabe K, Shoda T, Kotani T, Makino S, Hanafusa T (2009) Hemophagocytic syndrome as primary manifestation in a patient with systemic lupus erythematosus after parturition. Nihon Rinsho Meneki Gakkai Kaishi 32(1):66–70 DOI: 10.2177/jsci.32.66
24. Sawhney S, Woo P, Murray KJ (2001) Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 85(5):421–426 DOI: 10.1136/adc.85.5.421
25. Ravelli A, Viola S, De Benedetti F, Magni-Manzoni S, Tzialla C, Martini A (2001) Dramatic efficacy of cyclosporine A in macrophage activation syndrome. Clin Exp Rheumatol 19:108
26. Ueda Y, Yamashita H, Takahashi Y, Kaneko H, Kano T, Mimori A (2014) Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review. Clin Rheumatol 33(2):281–286. doi:10.1007/s10067-013-2451-8 DOI: 10.1007/s10067-013-2451-8
27. Torres Jiménez A, Solís Vallejo E, Zeferino Cruz M, Céspedes Cruz A, Sánchez Jara B (2014) Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide. Reumatol Clin 10(5):331–335. doi:10.1016/j.reuma.2013.05.013 DOI: 10.1016/j.reuma.2013.05.013
28. Takahashi H, Tsuboi H, Kurata I, Takahashi H, Inoue S, Ebe H, Yokosawa M, Hagiwara S, Hirota T, Asashima H, Kaneko S, Kawaguchi H, Kurashima Y, Miki H, Umeda N, Kondo Y, Ogishima H, Suzuki T, Matsumoto I, Sumida T (2015) Predictors of the response to treatment in acute lupus hemophagocytic syndrome. Lupus 24(7):659–668. doi:10.1177/0961203314559086 DOI: 10.1177/0961203314559086
29. Minoia F, Davì S, Horne A, Demirkaya E, Bovis F, Li C, Lehmberg K, Weitzman S, Insalaco A, Wouters C, Shenoi S, Espada G, Ozen S, Anton J, Khubchandani R, Russo R, Pal P, Kasapcopur O, Miettunen P, Maritsi D, Merino R, Shakoory B, Alessio M, Chasnyk V, Sanner H, Gao YJ, Huasong Z, Kitoh T, Avcin T, Fischbach M, Frosch M, Grom A, Huber A, Jelusic M, Sawhney S, Uziel Y, Ruperto N, Martini A, Cron RQ, Ravelli A, Pediatric Rheumatology International Trials Organization, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Histiocyte Society (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66(11):3160–3169. doi:10.1002/art.38802 DOI: 10.1002/art.38802
30. Ravelli A, Grom AA, Behrens EM, Cron RQ (2012) Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 13(4):289–298. doi:10.1038/gene.2012.3 DOI: 10.1038/gene.2012.3
31. Carvalheiras G, Anjo D, Mendonça T, Vasconcelos C, Farinha F (2010) Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus—case report and literature review. Lupus 19(6):756–761. doi:10.1177/0961203309354906 DOI: 10.1177/0961203309354906
32. Komiya Y, Takenaka K, Nagasaka K (2013) Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still’s disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab: a case report. Nihon Rinsho Meneki Gakkai Kaishi 36(6):478–483 DOI: 10.2177/jsci.36.478
33. Bakshi J, Hassan S, D'Cruz D, Chan A (2013) Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus. Lupus 22(14):1544–1546. doi:10.1177/0961203313504634 DOI: 10.1177/0961203313504634
34. Tayer-Shifman OE, Ben-Chetrit E (2015) Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome—successful use of PET-CT and anakinra in its diagnosis and treatment. Mod Rheumatol 25(6):954–957. doi:10.3109/14397595.2013.844403 DOI: 10.3109/14397595.2013.844403
35. Kamiya K, Kurasawa K, Arai S, Maezawa R, Hanaoka R, Kumano K, Fukuda T (2010) Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol 20(1):81–85. doi:10.1007/s10165-009-0231-8 DOI: 10.3109/s10165-009-0231-8
36. Takahashi N, Naniwa T, Banno S (2008) Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol 18(1):72–75 DOI: 10.3109/s10165-007-0006-z
37. Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ, PRINTO, PRCSG (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med 20 367(25):2396–2406. doi:10.1056/NEJMoa1205099 DOI: 10.1056/NEJMoa1205099
38. De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, Cuttica R, Ravelli A, Schneider R, Woo P, Wouters C, Xavier R, Zemel L, Baildam E, Burgos-Vargas R, Dolezalova P, Garay SM, Merino R, Joos R, Grom A, Wulffraat N, Zuber Z, Zulian F, Lovell D, Martini A, PRINTO, PRCSG (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 20 367(25):2385–2395. doi:10.1056/NEJMoa1112802 DOI: 10.1056/NEJMoa1112802
39. Li X, Qu B, Nie Y, Zhu G, Li W, Mu F (2014) Clinical features of macrophage activation syndrome in the adult northern Chinese population. Lupus 23(8):785–792. doi:10.1177/0961203314529467 DOI: 10.1177/0961203314529467
40. Huang W, Wang Y, Wang J, Zhang J, Wu L, Li S, Tang R, Zeng X, Chen J, Pei R, Wang Z (2014) Clinical characteristics of 192 adult hemophagocytic lymphohistiocytosis. Zhonghua Xue Ye Xue Za Zhi 35(9):796–801. doi:10.3760/cma.j.issn.0253-2727.2014.09.003
41. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146(5):598–604 DOI: 10.1016/j.jpeds.2004.12.016
42. Davì S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D'Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A, Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, the Histiocyte Society (2014) Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 66(10):2871–2880. doi:10.1002/art.38769 DOI: 10.1002/art.38769